NewcelX Ltd. — Form D

NewcelX Ltd. of KLOTEN, V8, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-13. The offering totals $3.4M, of which $3.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Tamar GaliliRelated PersonKloten, V8
Omri HagaiRelated PersonKloten, V8
Eran IohanRelated PersonKloten, V8
Kfir MolakandovRelated PersonKloten, V8
Liora OrenRelated PersonKloten, V8
Michel RevelRelated PersonKloten, V8
Olivier SamuelRelated PersonKloten, V8
Ronen TwitoRelated PersonKloten, V8
Alexander C. ZwyerRelated PersonKloten, V8
Gian-Marco Rinaldi de la CruzDirectorZurich, V8
Olivier SamuelDirectorKloten, V8
Alexander ZwyerDirectorZurich, V8
Alexander ZwyerExecutive OfficerZurich, V8
Nicole Fernandez-McGovernExecutive OfficerZurich, V8
Florence Allouche AkninDirectorZurich, V8
Ronald HafnerDirectorZurich, V8
Audrey GreenbergDirectorZurich, V8
Claudio L A BassettiDirectorZurich, V8
Gian-Marco L A Rinaldi de la CruzDirectorZurich, V8
Audrey L A GreenbergDirectorZurich, V8
Olivier L A SamuelDirectorZurich, V8
Gian-Marco LA RinaldiDirectorZurich, V8
Florence Allouche AkninDirectorZurich, V8
Elena Thyen-PighinExecutive OfficerZurich, V8
Audrey LA GreenbergDirectorZurich, V8

Other filings by this issuer (8)

FiledFormOfferingSold
2025-07-10D$1.0M$1.0M
2025-04-14D$2.0M$2.0M
2025-01-22D$500K$500K
2024-10-21D$7.2M$7.2M
2024-07-15D$787K$787K
2024-04-03D$1.8M$1.8M
2022-12-21D$30.0M$10.0M
2022-10-14D$4.0M$4.0M

More